eFFECTOR Therapeutics Inc
F:LWK1
eFFECTOR Therapeutics Inc
F:LWK1
Price:
9.1
EUR
Market Closed
Market Cap:
€1.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
eFFECTOR Therapeutics Inc
F:LWK1
|
US |
|
Guoguang Electric Co Ltd Chengdu
SSE:688776
|
CN |
|
A
|
AB&Company Co Ltd
TSE:9251
|
JP |
|
S
|
Sime Darby Plantation Bhd
KLSE:SIMEPLT
|
MY |
|
Daibiru Corp
TSE:8806
|
JP |
|
A
|
Ashok Alco-Chem Ltd
BSE:524594
|
IN |
|
Natural Resource Partners LP
NYSE:NRP
|
US |
|
M
|
M3-Brigade Acquisition V Corp
NASDAQ:MBAV
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of LWK1.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LWK1
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
LWK1 Competitors Multiples
eFFECTOR Therapeutics Inc Competitors
eFFECTOR Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
eFFECTOR Therapeutics Inc
F:LWK1
|
1.1m EUR | 0 | -0 | 0.7 | 0.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
366.3B USD | 6.1 | 89.2 | 14.8 | 20.5 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.4B USD | 6.2 | -96.2 | 951.3 | -107.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.8B USD | 5.2 | 24.7 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.6B USD | 5.8 | 20 | 12.5 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.6B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80B USD | 5.6 | 17.8 | 13.2 | 15.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68B AUD | 3.2 | 35.2 | 11.6 | 14.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
